Voyager Therapeutics Lands $60,000,000 Series B Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8188dfe7-dc75-463b-8e7c-552533ad8f31
Date
4/13/2015
Company Name
Voyager Therapeutics
Mailing Address
75 Sidney St. Cambridge, MA 02139 USA
Company Description
Voyager Therapeutics is developing life-changing gene therapies for fatal and debilitating diseases of the central nervous system. Our founders include scientific and clinical leaders in the fields of adeno-associated virus (AAV) gene therapy, expressed RNA interference and neuroscience.
Website
http://www.voyagertherapeutics.com
Transaction Type
Venture Equity
Transaction Amount
$60,000,000
Transaction Round
Series B
Proceeds Purposes
Proceeds from the financing will be used to advance the company’s product pipeline, which includes five clinical and preclinical programs, as well as its industry-leading adeno-associated virus (AAV) product engine.
M&A Terms
Venture Investor
Venture Investor
Venture Investor
Venture Investor